{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:44:19Z","timestamp":1784371459907,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:00:00Z","timestamp":1584748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.heliyon.2020.e03661","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T15:55:46Z","timestamp":1587052546000},"page":"e03661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Effect of nitazoxanide and spiramycin metronidazole combination in acute experimental toxoplasmosis"],"prefix":"10.1016","volume":"6","author":[{"given":"Amal","family":"FarahatAllam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel Youssef","family":"Shehab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerrmine Mogahed","family":"Fawzy Hussein Mogahed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda Fahmy","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmen","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa Fathi","family":"Abd El-Latif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12-13","key":"10.1016\/j.heliyon.2020.e03661_bib1","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tentera","year":"2000","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.heliyon.2020.e03661_bib2","series-title":"Opportunistic Infections: Toxoplasma, Sarcocystis, and Microsporidia","first-page":"1","article-title":"Biology of Toxoplasma gondii in cats and other animals","author":"Dubey","year":"2004"},{"issue":"6","key":"10.1016\/j.heliyon.2020.e03661_bib3","first-page":"467","article-title":"The history of Toxoplasma gondii\u2014the first 100 years","volume":"55","author":"Dubey","year":"2008","journal-title":"J\u00a0Euk Microb"},{"key":"10.1016\/j.heliyon.2020.e03661_bib4","series-title":"Principles and Practice of Infectious Diseases","first-page":"3123","article-title":"Toxoplasma gondii","author":"Montoya","year":"2011"},{"key":"10.1016\/j.heliyon.2020.e03661_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2334-14-33","article-title":"Congenital toxoplasmosis and prenatal care state programs","volume":"14","author":"Avelino","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.heliyon.2020.e03661_bib6","series-title":"Feigin and Cherry's Textbook of Pediatric Infectious Diseases","first-page":"2986","article-title":"Toxoplasmosis","author":"Mcauley","year":"2014"},{"issue":"9","key":"10.1016\/j.heliyon.2020.e03661_bib7","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0020-7519(99)00152-6","article-title":"HLA-class II genes modify outcome of Toxoplasma gondii infection","volume":"29","author":"Mack","year":"1999","journal-title":"Int. J. Parasitol."},{"issue":"9","key":"10.1016\/j.heliyon.2020.e03661_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138204","article-title":"A\u00a0systematic review and meta-analysis of the efficacy of anti-Toxoplasma gondii medicines in humans","volume":"10","author":"Wei","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.heliyon.2020.e03661_bib9","first-page":"51","article-title":"Oral trimethoprim-sulfamethoxazole in the treatment of cerebral toxoplasmosis in AIDS patients-a prospective study","volume":"94","author":"Francis","year":"2004","journal-title":"S.\u00a0Afr. Med. J."},{"issue":"11","key":"10.1016\/j.heliyon.2020.e03661_bib10","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.ophtha.2005.05.025","article-title":"Prospective randomized trial of trimethoprim\/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis","volume":"112","author":"Soheilian","year":"2005","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.heliyon.2020.e03661_bib11","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1128\/AAC.05183-11","article-title":"Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis","volume":"56","author":"Chew","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.heliyon.2020.e03661_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/1471-2334-14-349","article-title":"Assessment of laboratory methods used in the diagnosis of congenital toxoplasmosis after maternal treatment with spiramycin in pregnancy","volume":"14","author":"RodriguesIM","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2020.e03661_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/321008","article-title":"Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide","volume":"184","author":"Rossignol","year":"2001","journal-title":"J.\u00a0Infect. Dis."},{"issue":"6","key":"10.1016\/j.heliyon.2020.e03661_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.arcmed.2013.07.002","article-title":"Effect of nitaxozanide and pyrimethamine on astrocytes infected by Toxoplasma gondii in vitro","volume":"44","author":"Galv\u00e1n-Ram\u00edrez","year":"2013","journal-title":"Arch. Med. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2020.e03661_bib15","first-page":"152","article-title":"The survival of Toxoplasma gondii trophozoites in changes in osmotic pressure","volume":"54","author":"R\u00e4is\u00e4nen","year":"1976","journal-title":"Med. Biol."},{"issue":"8","key":"10.1016\/j.heliyon.2020.e03661_bib16","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.4049\/jimmunol.163.8.4503","article-title":"IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii","volume":"163","author":"Khan","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.heliyon.2020.e03661_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.micpath.2015.01.001","article-title":"Sulfamethoxazole-trimethoprim associated with resveratrol for the treatment of toxoplasmosis in mice: influence on the activity of enzymes involved in brain neurotransmission","volume":"79","author":"Bottari","year":"2015","journal-title":"Microb. Pathog."},{"issue":"12","key":"10.1016\/j.heliyon.2020.e03661_bib18","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1128\/AAC.01323-16","article-title":"Evaluation of propranolol effect on experimental acute and chronic toxoplasmosis using quantitative PCR","volume":"60","author":"Montazeri","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.heliyon.2020.e03661_bib19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.exppara.2012.05.001","article-title":"Initial characterization of an autoclaved Toxoplasma vaccine in mice","volume":"131","author":"Eissa","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.heliyon.2020.e03661_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exppara.2014.05.005","article-title":"Chitosan and silver nanoparticles: promising anti-Toxoplasma agents","volume":"143","author":"Gaafar","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.heliyon.2020.e03661_bib21","first-page":"54","article-title":"Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis","volume":"149","author":"El-Zawawy","year":"2015","journal-title":"ExpParasitol"},{"key":"10.1016\/j.heliyon.2020.e03661_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/978-1-61779-108-6_2","article-title":"Cell viability analysis using trypan blue: manual and automated methods","author":"Louis","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.heliyon.2020.e03661_bib23","article-title":"Measuring cell death by trypan blue uptake and light microscopy","volume":"7","author":"Crowley","year":"2016","journal-title":"Cold Spring Harb. Protoc."},{"issue":"1","key":"10.1016\/j.heliyon.2020.e03661_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1099\/00221287-75-1-111","article-title":"Scanning electron microscopy of Toxoplasma gondii","volume":"75","author":"Klainer","year":"1973","journal-title":"J.\u00a0Gen. Microbiol."},{"key":"10.1016\/j.heliyon.2020.e03661_bib25","series-title":"A\u00a0Simple Guide to IBM SPSS: for Version 20.0: Belmont, Calif","author":"Kirkpatrick","year":"2013"},{"key":"10.1016\/j.heliyon.2020.e03661_bib26","series-title":"Interpretation and Uses of Medical Statistics.fourth ed. Oxford Scientific Publications","first-page":"411","article-title":"Statistical analysis","author":"Leslie","year":"1991"},{"issue":"1","key":"10.1016\/j.heliyon.2020.e03661_bib27","first-page":"91","article-title":"An introduction to survival statistics: kaplan-meier analysis","volume":"7","author":"Dudley","year":"2016","journal-title":"J\u00a0Adv Pract Oncol"},{"key":"10.1016\/j.heliyon.2020.e03661_bib28","series-title":"Practical Nonparametric Statistics","first-page":"428","author":"Conover","year":"1999"},{"issue":"12","key":"10.1016\/j.heliyon.2020.e03661_bib29","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/AAC.02009-15","article-title":"Clinically available medicines demonstrating anti-Toxoplasma activity","volume":"59","author":"Neville","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.heliyon.2020.e03661_bib30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijantimicag.2004.09.015","article-title":"Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis","volume":"25","author":"Gruji\u0107","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"8","key":"10.1016\/j.heliyon.2020.e03661_bib31","article-title":"Toxoplasma gondii protein disulfide isomerase (TgPDI) is a novel vaccine candidate against toxoplasmosis","volume":"8","author":"Wang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.heliyon.2020.e03661_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.exppara.2015.06.005","article-title":"Could miltefosine be used as a therapy for toxoplasmosis?","volume":"157","author":"Eissa","year":"2015","journal-title":"Exp. Parasitol."},{"issue":"5","key":"10.1016\/j.heliyon.2020.e03661_bib33","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1084\/jem.178.5.1465","article-title":"Emergence of NK1. 1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice","volume":"178","author":"Denkers","year":"1993","journal-title":"Jew. Expon. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2020.e03661_bib34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1128\/AAC.9.2.222","article-title":"Trimethoprim-sulfamethoxazole in murine toxoplasmosis","volume":"9","author":"Remington","year":"1976","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.heliyon.2020.e03661_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4269\/ajtmh.1979.28.445","article-title":"The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo","volume":"28","author":"Grossman","year":"1979","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.heliyon.2020.e03661_bib36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00436-015-4759-6","article-title":"Effect of Nigella sativa oil on experimental toxoplasmosis","volume":"115","author":"Mady","year":"2016","journal-title":"Parasitol. Res."},{"issue":"7","key":"10.1016\/j.heliyon.2020.e03661_bib37","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/EC.00096-13","article-title":"A\u00a0SAS-6-like protein suggests that the Toxoplasma conoid complex evolved from flagellar components","volume":"12","author":"de Leon","year":"2013","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.heliyon.2020.e03661_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jac\/22.Supplement_B.87","article-title":"Activity of spiramycin against Toxoplasma gondii in vitro, in experimental infections and in human infection","volume":"22","author":"Chang","year":"1988","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.heliyon.2020.e03661_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.actatropica.2019.04.013","article-title":"Evaluation of nitazoxanide as anovel drug for the treatment of acute and chronic toxoplasmosis","volume":"195","author":"El-Kowranya","year":"2019","journal-title":"Acta Trop."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020305065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020305065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T09:50:58Z","timestamp":1773654658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844020305065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2405844020305065"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03661","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of nitazoxanide and spiramycin metronidazole combination in acute experimental toxoplasmosis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e03661"}}